Clinical Trial Update: Hyaluronic Acid in the Treatment of Hyposalivation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating hyaluronic acid for xerostomia due to hyposecretion of the salivary glands; enrollment is ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Xerostomia

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Xerostomia Due to Hyposecretion of Salivary Gland | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION